speb/financial-data huggingface dataset:
MED.DE balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 41731051.00
MED.DE income_statement (annual, 2023-12-31) — Normalized EBITDA: 101265261.00
MED.DE income_statement (annual, 2023-12-31) — Normalized Income: -10776122.00
MED.DE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 78001322.00
MED.DE income_statement (annual, 2023-12-31) — Operating Income: 11696167.00
MED.DE income_statement (annual, 2023-12-31) — Operating Revenue: 730100000.00
MED.DE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Current Assets: -495.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: -149.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 6115127.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Inventories: 364.00
MED.DE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 20687171.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1259.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 38899935.00
MED.DE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 1100000.00
MED.DE income_statement (annual, 2023-12-31) — Other Operating Expenses: 47700000.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Payable: 25401809.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Properties: -7000.00
MED.DE balance_sheet (annual, 2023-12-31) — Other Receivables: 71808001.00
MED.DE income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (annual, 2023-12-31) — Payables: 50107084.00
MED.DE balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37041000.00
MED.DE balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2508503.00
MED.DE income_statement (annual, 2023-12-31) — Pretax Income: -8688857.00
MED.DE balance_sheet (annual, 2023-12-31) — Properties: 0.00
MED.DE cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -3157562.00
MED.DE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -42144.00
MED.DE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -34418675.00
MED.DE balance_sheet (annual, 2023-12-31) — Raw Materials: 7296000.00
MED.DE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 135500000.00
MED.DE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 86005243.00
MED.DE income_statement (annual, 2023-12-31) — Rent And Landing Fees: 4300000.00
MED.DE income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 4300000.00
MED.DE balance_sheet (annual, 2023-12-31) — Retained Earnings: -16367284.00
MED.DE cash_flow (annual, 2023-12-31) — Sale Of Business: 8648295.00
MED.DE cash_flow (annual, 2023-12-31) — Sale Of PPE: 469649.00
MED.DE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 3300000.00
MED.DE income_statement (annual, 2023-12-31) — Selling General And Administration: 18000000.00
MED.DE balance_sheet (annual, 2023-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 195917976.00
MED.DE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 173117849.00
MED.DE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (annual, 2023-12-31) — Tax Provision: 2035123.00
MED.DE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.15
MED.DE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 0.00
MED.DE cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 2825478.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Assets: 880501922.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Capitalization: 287336798.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Debt: 479824412.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 196029397.00
MED.DE income_statement (annual, 2023-12-31) — Total Expenses: 718403833.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 684472525.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 580675179.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 538233465.00
MED.DE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 12721775.00
MED.DE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 8494964.00
MED.DE balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 1507000.00
MED.DE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
MED.DE balance_sheet (annual, 2023-12-31) — Working Capital: 153587683.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 333831038.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 36891699.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Current Debt: 26600793.00
MED.DE cash_flow (quarterly, 2024-09-30) — Deferred Tax: 2778043.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Investmentsin Subsidiariesat Cost: 58822.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Land And Improvements: 104132466.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 65429539.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 58822.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 40599224.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: -518168903.00
MED.DE income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 16076839.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Other Payable: 86208118.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Other Properties: 2714476.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 9791484.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Prepaid Assets: 5275496.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
MED.DE income_statement (quarterly, 2024-09-30) — Total Operating Income As Reported: 22523201.00
MED.DE balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 40261242.00
MED.DE income_statement (annual, 2024-12-31) — +Operating Expense: 572600000.00
MED.DE income_statement (quarterly, 2024-12-31) — +Operating Expense: 143212133.00
MED.DE income_statement (annual, 2024-12-31) — +Total Revenue: 748800000.00
MED.DE income_statement (quarterly, 2024-12-31) — +Total Revenue: 190579596.00
MED.DE balance_sheet (annual, 2024-12-31) — Accounts Payable: 17963855.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 17963855.00
MED.DE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 99569383.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 99569383.00
MED.DE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -602711000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -602711000.00
MED.DE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3985000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3985000.00
MED.DE income_statement (annual, 2024-12-31) — Amortization: 3000000.00
MED.DE balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 76702.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 76702.00
MED.DE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 625881.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 567059.00
MED.DE income_statement (annual, 2024-12-31) — Basic Average Shares: 47500000.00
MED.DE income_statement (annual, 2024-12-31) — Basic EPS: 0.52
MED.DE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 115288680.00
MED.DE cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 129993699.00
MED.DE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 575211000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 575211000.00
MED.DE cash_flow (annual, 2024-12-31) — Capital Expenditure: -44689946.00
MED.DE cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -14499344.00
MED.DE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 397167477.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 397167477.00
MED.DE balance_sheet (annual, 2024-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 107563091.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 107563091.00
MED.DE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 115469091.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 107563091.00
MED.DE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -15418659.00
MED.DE cash_flow (quarterly, 2024-12-31) — Change In Other Current Assets: -4109359.00
MED.DE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -193219.00
MED.DE cash_flow (quarterly, 2024-12-31) — Change In Other Current Liabilities: -2509121.00
MED.DE cash_flow (annual, 2024-12-31) — Change In Working Capital: -21008648.00
MED.DE cash_flow (quarterly, 2024-12-31) — Change In Working Capital: -11396334.00
MED.DE cash_flow (annual, 2024-12-31) — Changes In Cash: -7725589.00
MED.DE cash_flow (quarterly, 2024-12-31) — Changes In Cash: -22430608.00
MED.DE balance_sheet (annual, 2024-12-31) — Common Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Common Stock: 47500000.00
MED.DE cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: 0.00
MED.DE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 222506055.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 222506055.00
MED.DE balance_sheet (annual, 2024-12-31) — Construction In Progress: 42171000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 42171000.00
MED.DE income_statement (annual, 2024-12-31) — Cost Of Revenue: 125800000.00
MED.DE income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 29266851.00
MED.DE balance_sheet (annual, 2024-12-31) — Current Assets: 297585432.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Current Assets: 297585432.00
MED.DE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 26592831.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 26592831.00
MED.DE balance_sheet (annual, 2024-12-31) — Current Debt: 1863455.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Current Debt: 1863455.00
MED.DE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 28456286.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 28456286.00
MED.DE balance_sheet (annual, 2024-12-31) — Current Liabilities: 166009886.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 166009886.00
MED.DE balance_sheet (annual, 2024-12-31) — Current Provisions: 10954702.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Current Provisions: 10954702.00
MED.DE cash_flow (annual, 2024-12-31) — Deferred Tax: 7206397.00
MED.DE cash_flow (quarterly, 2024-12-31) — Deferred Tax: 3744369.00
MED.DE cash_flow (annual, 2024-12-31) — Depreciation: 50281796.00
MED.DE cash_flow (quarterly, 2024-12-31) — Depreciation: 13132247.00
MED.DE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 50281796.00
MED.DE cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 13132247.00
MED.DE income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 50300000.00
MED.DE income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 13150451.00
MED.DE income_statement (annual, 2024-12-31) — Depreciation Income Statement: 47300000.00
MED.DE income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 10150451.00
MED.DE income_statement (annual, 2024-12-31) — Diluted Average Shares: 47500000.00
MED.DE income_statement (annual, 2024-12-31) — Diluted EPS: 0.52
MED.DE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 24839397.00
MED.DE income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 9943146.00
MED.DE income_statement (annual, 2024-12-31) — EBIT: 56109908.00
MED.DE income_statement (quarterly, 2024-12-31) — EBIT: 19607921.00
MED.DE income_statement (annual, 2024-12-31) — EBITDA: 106409908.00
MED.DE income_statement (quarterly, 2024-12-31) — EBITDA: 32758372.00
MED.DE cash_flow (annual, 2024-12-31) — End Cash Position: 107563091.00
MED.DE cash_flow (quarterly, 2024-12-31) — End Cash Position: 107563091.00
MED.DE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -73162145.00
MED.DE cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -36866488.00
MED.DE cash_flow (annual, 2024-12-31) — Free Cash Flow: 35876006.00
MED.DE cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 6532658.00
MED.DE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -226350.00
MED.DE cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: -15439.00
MED.DE income_statement (annual, 2024-12-31) — General And Administrative Expense: 16500000.00
MED.DE balance_sheet (annual, 2024-12-31) — Goodwill: 16395000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Goodwill: 16395000.00
MED.DE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 24714648.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 24714648.00
MED.DE balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 103554000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 103554000.00
MED.DE balance_sheet (annual, 2024-12-31) — Gross PPE: 1136008000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1136008000.00
MED.DE income_statement (annual, 2024-12-31) — Gross Profit: 623000000.00
MED.DE income_statement (quarterly, 2024-12-31) — Gross Profit: 161312745.00
MED.DE income_statement (annual, 2024-12-31) — Interest Expense: 23990491.00
MED.DE income_statement (quarterly, 2024-12-31) — Interest Expense: 5903461.00
MED.DE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 23990491.00
MED.DE income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 5903461.00
MED.DE income_statement (annual, 2024-12-31) — Interest Income: 2623252.00
MED.DE income_statement (quarterly, 2024-12-31) — Interest Income: 588582.00
MED.DE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2623252.00
MED.DE income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 588582.00
MED.DE cash_flow (annual, 2024-12-31) — Interest Paid Cff: -22784672.00
MED.DE cash_flow (quarterly, 2024-12-31) — Interest Paid Cff: -5350473.00
MED.DE cash_flow (annual, 2024-12-31) — Interest Received Cfo: 2620413.00
MED.DE cash_flow (quarterly, 2024-12-31) — Interest Received Cfo: 585743.00
MED.DE balance_sheet (annual, 2024-12-31) — Inventory: 7664166.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Inventory: 7664166.00
MED.DE balance_sheet (annual, 2024-12-31) — Invested Capital: 289466397.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Invested Capital: 289466397.00
MED.DE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -15129396.00
MED.DE cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -6596122.00
MED.DE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 625881.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 567059.00
MED.DE balance_sheet (annual, 2024-12-31) — Investmentsin Subsidiariesat Cost: 58822.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Investmentsin Subsidiariesat Cost: 58822.00
MED.DE balance_sheet (annual, 2024-12-31) — Land And Improvements: 285179000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 285179000.00
MED.DE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 370574646.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 370574646.00
MED.DE balance_sheet (annual, 2024-12-31) — Long Term Debt: 65096887.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 65096887.00
MED.DE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 435671533.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 435671533.00
MED.DE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 58822.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 58822.00
MED.DE balance_sheet (annual, 2024-12-31) — Long Term Provisions: 2383578.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 2383578.00
MED.DE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 233447000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 233447000.00
MED.DE balance_sheet (annual, 2024-12-31) — Minority Interest: 231574.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Minority Interest: 231574.00
MED.DE income_statement (annual, 2024-12-31) — Minority Interests: -73623.00
MED.DE income_statement (quarterly, 2024-12-31) — Minority Interests: -16945.00
MED.DE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 9500000.00
MED.DE cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: -11374138.00
MED.DE income_statement (annual, 2024-12-31) — Net Income: 24839397.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Income: 9943146.00
MED.DE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 24839397.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 9943146.00
MED.DE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 24913020.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 9960091.00
MED.DE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 24839397.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 9943146.00
MED.DE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 24839397.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 9943146.00
MED.DE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 24913020.00
MED.DE cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: 9960091.00
MED.DE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 24913020.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 9960091.00
MED.DE cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -6647885.00
MED.DE cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -4110419.00
MED.DE income_statement (annual, 2024-12-31) — Net Interest Income: -21367239.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Interest Income: -5314879.00
MED.DE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -9800.00
MED.DE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -21367239.00
MED.DE income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -5314879.00
MED.DE cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -26282621.00
MED.DE cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -25322656.00
MED.DE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 19096127.00
MED.DE balance_sheet (annual, 2024-12-31) — Net PPE: 533297000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Net PPE: 533297000.00
MED.DE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -37067838.00
MED.DE cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -10197892.00
MED.DE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 197791407.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 197791407.00
MED.DE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 11136799.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 11136799.00
MED.DE balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 38198281.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 38198281.00
MED.DE income_statement (annual, 2024-12-31) — Normalized EBITDA: 106409908.00
MED.DE income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 32758372.00
MED.DE income_statement (annual, 2024-12-31) — Normalized Income: 24839397.00
MED.DE income_statement (quarterly, 2024-12-31) — Normalized Income: 9943146.00
MED.DE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 80565952.00
MED.DE cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 21032002.00
MED.DE income_statement (annual, 2024-12-31) — Operating Income: 50400000.00
MED.DE income_statement (quarterly, 2024-12-31) — Operating Income: 18100612.00
MED.DE income_statement (annual, 2024-12-31) — Operating Revenue: 748800000.00
MED.DE income_statement (quarterly, 2024-12-31) — Operating Revenue: 190579596.00
MED.DE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Current Assets: -126.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Current Assets: -126.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 15.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 15.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 8319648.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 8319648.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Inventories: 166.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Inventories: 166.00
MED.DE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 19797013.00
MED.DE cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 5751823.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1246.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Non Current Assets: 1246.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 39300029.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 39300029.00
MED.DE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 900000.00
MED.DE income_statement (annual, 2024-12-31) — Other Operating Expenses: 41900000.00
MED.DE income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -9929733.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Payable: 43032034.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Payable: 43032034.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Receivables: 72081458.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Other Receivables: 79987458.00
MED.DE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 7906000.00
MED.DE income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (annual, 2024-12-31) — Payables: 74190883.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Payables: 74110883.00
MED.DE balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37345000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 37345000.00
MED.DE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 2724758.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 2724758.00
MED.DE income_statement (annual, 2024-12-31) — Pretax Income: 32119417.00
MED.DE income_statement (quarterly, 2024-12-31) — Pretax Income: 13704460.00
MED.DE balance_sheet (annual, 2024-12-31) — Properties: 0.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MED.DE cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -6647885.00
MED.DE cash_flow (quarterly, 2024-12-31) — Purchase Of Intangibles: -4110419.00
MED.DE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -9800.00
MED.DE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -38042061.00
MED.DE cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -10388925.00
MED.DE balance_sheet (annual, 2024-12-31) — Raw Materials: 7664000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Raw Materials: 7664000.00
MED.DE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 125800000.00
MED.DE income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 29266851.00
MED.DE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 50281796.00
MED.DE income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 13132247.00
MED.DE income_statement (annual, 2024-12-31) — Rent And Landing Fees: 4900000.00
MED.DE income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 4900000.00
MED.DE balance_sheet (annual, 2024-12-31) — Retained Earnings: 8472113.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 8472113.00
MED.DE cash_flow (annual, 2024-12-31) — Sale Of Business: 9500000.00
MED.DE cash_flow (quarterly, 2024-12-31) — Sale Of Business: -11374138.00
MED.DE cash_flow (annual, 2024-12-31) — Sale Of PPE: 974223.00
MED.DE cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 191033.00
MED.DE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 2600000.00
MED.DE income_statement (annual, 2024-12-31) — Selling General And Administration: 19100000.00
MED.DE balance_sheet (annual, 2024-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Share Issued: 47500000.00
MED.DE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 222506055.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 222506055.00
MED.DE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 197791407.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 197791407.00
MED.DE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (annual, 2024-12-31) — Tax Provision: 7206397.00
MED.DE income_statement (quarterly, 2024-12-31) — Tax Provision: 3744369.00
MED.DE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
MED.DE income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.27
MED.DE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 0.00
MED.DE cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -3017689.00
MED.DE cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -730498.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Assets: 905905936.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Assets: 905905936.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Capitalization: 287602942.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 287602942.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Debt: 464127819.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Debt: 464127819.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 222737629.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 222737629.00
MED.DE income_statement (annual, 2024-12-31) — Total Expenses: 698400000.00
MED.DE income_statement (quarterly, 2024-12-31) — Total Expenses: 172478984.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 683168307.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 683168307.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 608320504.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 608320504.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 517158421.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 517158421.00
MED.DE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 53486656.00
MED.DE income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 19019339.00
MED.DE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 13194994.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 13114994.00
MED.DE balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 1605000.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 1605000.00
MED.DE balance_sheet (annual, 2024-12-31) — Working Capital: 131575546.00
MED.DE balance_sheet (quarterly, 2024-12-31) — Working Capital: 131575546.00
MED.DE income_statement (quarterly, 2025-03-31) — +Operating Expense: 134280980.00
MED.DE income_statement (quarterly, 2025-03-31) — +Total Revenue: 176888755.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 10976979.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 89089043.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 76702.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 534260.00
MED.DE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 47500000.00
MED.DE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
MED.DE cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 107372852.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 337872445.00
MED.DE cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -10770029.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 390984145.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Capital Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 105030342.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 113901591.00
MED.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -3699583.00
MED.DE cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 8187925.00
MED.DE cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 884697.00
MED.DE cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2384883.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Common Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 223501026.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 46532954.00
MED.DE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 31505398.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Current Assets: 296869581.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 26703015.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Current Debt: 1323559.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 28026574.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 164147199.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Current Provisions: 7556260.00
MED.DE cash_flow (quarterly, 2025-03-31) — Depreciation: 12859509.00
MED.DE cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 12859509.00
MED.DE income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 12859509.00
MED.DE income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 12859509.00
MED.DE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 47500000.00
MED.DE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
MED.DE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -162806.00
MED.DE income_statement (quarterly, 2025-03-31) — EBIT: 5595412.00
MED.DE income_statement (quarterly, 2025-03-31) — EBITDA: 18454921.00
MED.DE cash_flow (quarterly, 2025-03-31) — End Cash Position: 104987969.00
MED.DE cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -12296372.00
MED.DE cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 6464806.00
MED.DE cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -37391.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Goodwill: 16395079.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 24559910.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Gross PPE: 530469355.00
MED.DE income_statement (quarterly, 2025-03-31) — Gross Profit: 145383357.00
MED.DE income_statement (quarterly, 2025-03-31) — Interest Expense: 5587288.00
MED.DE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 5587288.00
MED.DE income_statement (quarterly, 2025-03-31) — Interest Income: 369611.00
MED.DE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 369611.00
MED.DE cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -5772328.00
MED.DE cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 369611.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Inventory: 7327971.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 289576068.00
MED.DE cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -7323346.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 534260.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 58822.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 101084058.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 364281130.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 64751483.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 429032613.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 58822.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 2333508.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 42701034.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Minority Interest: 307482.00
MED.DE income_statement (quarterly, 2025-03-31) — Minority Interests: -66184.00
MED.DE cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 3364892.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Income: -162806.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -162806.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -96622.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -162806.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -162806.00
MED.DE cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 5225801.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -96622.00
MED.DE cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -462321.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Interest Income: -5217677.00
MED.DE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -5217677.00
MED.DE cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -340712.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Net PPE: 530469355.00
MED.DE cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -10225917.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 198941116.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 11394570.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 36998711.00
MED.DE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 18454921.00
MED.DE income_statement (quarterly, 2025-03-31) — Normalized Income: -162806.00
MED.DE cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 17234835.00
MED.DE income_statement (quarterly, 2025-03-31) — Operating Income: 11102377.00
MED.DE income_statement (quarterly, 2025-03-31) — Operating Revenue: 176888755.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 8164831.00
MED.DE cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1668004.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 40848839.00
MED.DE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -5876576.00
MED.DE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 16320963.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Other Payable: 92785337.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Other Properties: 2278864.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 81262299.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 8871249.00
MED.DE income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Payables: 111938574.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 5211975.00
MED.DE income_statement (quarterly, 2025-03-31) — Pretax Income: 8124.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MED.DE cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -462321.00
MED.DE cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -10307708.00
MED.DE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 31505398.00
MED.DE income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12859509.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 8309307.00
MED.DE cash_flow (quarterly, 2025-03-31) — Sale Of Business: 3364892.00
MED.DE cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 81791.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Share Issued: 47500000.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 223501026.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 198941116.00
MED.DE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MED.DE income_statement (quarterly, 2025-03-31) — Tax Provision: 104746.00
MED.DE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
MED.DE cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -399388.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Assets: 897169378.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 288252509.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Debt: 457059187.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 223808508.00
MED.DE income_statement (quarterly, 2025-03-31) — Total Expenses: 165786378.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 673360870.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 600299797.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 509213671.00
MED.DE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 5225801.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 8176258.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 40848839.00
MED.DE balance_sheet (quarterly, 2025-03-31) — Working Capital: 132722382.00
MED.DE income_statement (quarterly, 2025-06-30) — +Operating Expense: 151338383.00
MED.DE income_statement (quarterly, 2025-06-30) — +Total Revenue: 198955421.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10122125.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 90713667.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 129391829.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 69932.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 534260.00
MED.DE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 49389510.00
MED.DE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.20
MED.DE cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 104987969.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Buildings And Improvements: 334839951.00
MED.DE cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -12731158.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 389080029.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Capital Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 100045778.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 110188282.00
MED.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -11013645.00
MED.DE cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -2165814.00
MED.DE cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -13111234.00
MED.DE cash_flow (quarterly, 2025-06-30) — Changes In Cash: -5132430.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Common Stock: 47500000.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 231864854.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 51345478.00
MED.DE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 30489275.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Current Assets: 300291563.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 27088049.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Current Debt: 1832439.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 28920488.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 164603472.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Current Provisions: 7784785.00
MED.DE cash_flow (quarterly, 2025-06-30) — Depreciation: 13073740.00
MED.DE cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 13073740.00
MED.DE income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 13073741.00
MED.DE income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 13073741.00
MED.DE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 49389510.00
MED.DE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.20
MED.DE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 9877902.00
MED.DE income_statement (quarterly, 2025-06-30) — EBIT: 17615750.00
MED.DE income_statement (quarterly, 2025-06-30) — EBITDA: 30689491.00
MED.DE cash_flow (quarterly, 2025-06-30) — End Cash Position: 100045778.00
MED.DE cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -13338696.00
MED.DE cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 5476507.00
MED.DE cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -1091.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Goodwill: 16395079.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 24435325.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Gross PPE: 532484919.00
MED.DE income_statement (quarterly, 2025-06-30) — Gross Profit: 168466146.00
MED.DE income_statement (quarterly, 2025-06-30) — Interest Expense: 5592249.00
MED.DE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 5592249.00
MED.DE income_statement (quarterly, 2025-06-30) — Interest Income: 368137.00
MED.DE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 368137.00
MED.DE cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -4744382.00
MED.DE cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 365270.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Inventory: 7448012.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 298104732.00
MED.DE cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -10001399.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 534260.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Investmentsin Subsidiariesat Cost: 58822.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 102358313.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 361991980.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 64407439.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 426399419.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 58822.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 2333508.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 41723248.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Minority Interest: 399968.00
MED.DE income_statement (quarterly, 2025-06-30) — Minority Interests: -89245.00
MED.DE cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 2604281.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Income: 9877902.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 9877902.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9967147.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 9877902.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 9877902.00
MED.DE cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 4644725.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 9967147.00
MED.DE cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -889851.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Interest Income: -5224112.00
MED.DE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -5224112.00
MED.DE cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -338550.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Net PPE: 532484919.00
MED.DE cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -11835679.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 207429529.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 11540929.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 36719239.00
MED.DE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 30689491.00
MED.DE income_statement (quarterly, 2025-06-30) — Normalized Income: 9877902.00
MED.DE cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 18207665.00
MED.DE income_statement (quarterly, 2025-06-30) — Operating Income: 17127763.00
MED.DE income_statement (quarterly, 2025-06-30) — Operating Revenue: 198955421.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 47500000.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 8040246.00
MED.DE cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 11884753.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 40046188.00
MED.DE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 18432266.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Other Payable: 89894266.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Other Properties: 2217929.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 85408079.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 10142504.00
MED.DE income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Payables: 109599074.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 6463591.00
MED.DE income_statement (quarterly, 2025-06-30) — Pretax Income: 12023501.00
MED.DE balance_sheet (quarterly, 2025-06-30) — Properties: 0.00